These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18942338)

  • 1. [Essential thrombocythemia as critical stroke risk factor--case report].
    Tomczykiewicz K; Staszewski J; Wajs J; Hałka J
    Pol Merkur Lekarski; 2008 Aug; 25(146):158-60. PubMed ID: 18942338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemic stroke as a presentation of essential thrombocythemia. Four case reports].
    Mallada-Frechin J; Abellán-Miralles I; Medrano V; Fernández-Izquierdo S; Piqueras-Rodríguez L
    Rev Neurol; 2004 Jun 1-15; 38(11):1032-4. PubMed ID: 15202080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 6. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial thromboses and essential thrombocythemia in young patients].
    Decoulx E; Millaire A; Jude B; Marquand A; Tison E; Bauters F; Ducloux G
    Ann Cardiol Angeiol (Paris); 1990 Jun; 39(6):347-50. PubMed ID: 2400197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioembolic stroke: call for a multidisciplinary approach.
    Babarro EG; Rego AR; González-Juanatey JR
    Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
    Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
    Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV; Dewilde S; Singer DE; Goldhaber SZ; Monz BU; Plumb JM
    Am Heart J; 2009 Jun; 157(6):1064-73. PubMed ID: 19464418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke: a case review.
    Meister J; Levy D
    Clin Excell Nurse Pract; 2000 Jul; 4(4):212-5. PubMed ID: 11261081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Essential thrombocythemia and cerebral ischemic accident: discussion of two cases].
    Alecu C; Abraham P; Ternisien C; Enon B; Saumet JL
    J Mal Vasc; 1999 Oct; 24(4):300-2. PubMed ID: 10582180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.